Regarding liver status, the AWG group showed higher levels of ALT and G-GTP, and a higher prevalence rate of NAFLD (AWG group vs. non-AWG group; 3.8% vs. 16.7%, p < 0.001). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.